CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Derian, C. K.
Right arrow Articles by Andrade-Gordon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Derian, C. K.
Right arrow Articles by Andrade-Gordon, P.

Cell Growth & Differentiation, Vol 8, Issue 7 743-749, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Differential regulation of human keratinocyte growth and differentiation by a novel family of protease-activated receptors

CK Derian, AJ Eckardt and P Andrade-Gordon
R.W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477-0776, USA.

Thrombin receptor (ThrR) and protease-activated receptor-2 (PAR-2) are members of a unique G protein-coupled receptor family, which are characterized by the unveiling of a tethered peptide ligand upon proteolysis of their NH2 terminus. We have previously shown that cultured human basal keratinocytes express both receptors (R.J. Santulli et al., Proc. Natl. Acad. Sci. USA, 92: 9151-9155, 1995); however, their functional role in epidermal physiology has yet to be described. In the present study, we determined the effects of receptor activation on keratinocyte cell growth and differentiation using thrombin (selective for ThrR), SLIGRL (selective for PAR-2), and SFLLRN (stimulates ThrR and PAR-2), as agonists. ThrR stimulation enhanced cell growth in a dose-dependent manner in the absence of growth factors (epidermal growth factor and bovine pituitary extract). In contrast, under the same conditions, activation of PAR-2 led to the inhibition of cell growth. This inhibitory activity by PAR-2 activation was also observed in the presence of growth factors. Activation of both receptors diminished protein expression of the differentiation marker transglutaminase type 1 induced by either calcium or IFN-gamma. Calcium-induced involucrin expression was also decreased. These results indicate that PAR-2 and ThrR differentially modulate keratinocyte function and may provide an important regulatory function in the epidermis by altering the functional state of keratinocytes.


This article has been cited by other articles:


Home page
IOVSHome page
R. Lang, P. I. Song, F. J. Legat, R. M. Lavker, B. Harten, H. Kalden, E. F. Grady, N. W. Bunnett, C. A. Armstrong, and J. C. Ansel
Human Corneal Epithelial Cells Express Functional PAR-1 and PAR-2
, January 1, 2003; 44(1): 99 - 105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
L. S. Chambers, J. L. Black, P. Poronnik, and P. R. A. Johnson
Functional effects of protease-activated receptor-2 stimulation on human airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1369 - L1378.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. R. Macfarlane, M. J. Seatter, T. Kanke, G. D. Hunter, and R. Plevin
Proteinase-Activated Receptors
Pharmacol. Rev., June 1, 2001; 53(2): 245 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E. R. Sharlow, C. S. Paine, L. Babiarz, M. Eisinger, S. Shapiro, and M. Seiberg
The protease-activated receptor-2 upregulates keratinocyte phagocytosis
J. Cell Sci., September 1, 2000; 113(17): 3093 - 3101.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. A. Akers, M. Parsons, M. R. Hill, M. D. Hollenberg, S. Sanjar, G. J. Laurent, and R. J. McAnulty
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L193 - L201.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. P. Damiano, W.-M. Cheung, R. J. Santulli, W.-P. Fung-Leung, K. Ngo, R. D. Ye, A. L. Darrow, C. K. Derian, L. de Garavilla, and P. Andrade-Gordon
Cardiovascular Responses Mediated by Protease-Activated Receptor-2 (PAR-2) and Thrombin Receptor (PAR-1) are Distinguished in Mice Deficient in PAR-2 or PAR-1
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 671 - 678.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
O. Dery, C. U. Corvera, M. Steinhoff, and N. W. Bunnett
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1429 - C1452.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.